REFERENCES
- Heinz FX, Stiasny K. Flaviviruses and flavivirus vaccines. Vaccine. 2012;30:4301–4306.
- Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med. 2004;10:S98–S109.
- Monath TP. (1990). Flaviviruses. (ARMY MEDICAL RESEARCH INST OF INFECTIOUS DISEASES FORT DETRICK MD).
- Solomon T, Mallewa M. Dengue and other emerging flaviviruses. J. Infect. 2001;42:104–115.
- Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89:766–774.
- Gould GW, Lippincott-Schwartz J. New roles for endosomes: from vesicular carriers to multi-purpose platforms. Nat Rev Mol Cell Biol. 2009;10:287–292.
- Kowal J, Tkach M, Théry C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol. 2014;29:116–125.
- McAndrews KM, Kalluri R. Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer. 2019;18:52.
- Go G-w, Mani A. Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J Biol Med. 2012;85:19–28.
- Goldstein JL, Brown MS. Binding and degradation of Low density lipoproteins by cultured human fibroblasts comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974;249:5153–5162.
- Brown MS, Herz J, Goldstein JL. Calcium cages, acid baths and recycling receptors. Nature. 1997;388:629–630.
- Finkelshtein D, Werman A, Novick D, et al. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc Natl Acad Sci USA. 2013;110:7306–7311.
- Monazahian M, Bohme I, Bonk S, et al. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol. 1999;57:223–229.
- Wunschmann S, Medh JD, Klinzmann D, et al. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol. 2000;74:10055–10062.
- Finkelshtein D, Werman A, Novick D, et al. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc Natl Acad Sci U S A. 2013;110:7306–7311.
- Fischer DG, Tal N, Novick D, et al. An antiviral soluble form of the LDL receptor induced by interferon. Science. 1993;262:250–253.
- Bochkov YA, Gern JE. Rhinoviruses and their receptors: implications for allergic disease. Curr Allergy Asthma Rep. 2016;16:30.
- Wei J-c, Huang Y-z, Zhong D-k, et al. Design and evaluation of a multi-epitope peptide against Japanese encephalitis virus infection in BALB/c mice. Biochem Biophys Res Commun. 2010;396:787–792.
- Zhang CM, Gao L, Zheng YJ, et al. Berbamine protects the heart from ischemia/reperfusion injury by maintaining cytosolic Ca(2+) homeostasis and preventing calpain activation. Circ J. 2012;76:1993–2002.
- Hu H, Zhou S, Sun X, et al. A potent antiarrhythmic drug N-methyl berbamine extends the action potential through inhibiting both calcium and potassium currents. J Pharmacol Sci. 2020;142:131–139.
- Guo ZB, Fu JG. [Progress of cardiovascular pharmacologic study on berbamine]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005;25:765–768.
- Li BY, Qiao GF, Zhao YL, et al. Effects of berbamine on ATP-induced [Ca2+]i mobilization in cultured vascular smooth muscle cells and cardiomyocytes. Zhongguo Yao Li Xue Bao. 1999;20:705–708.
- Qiao GF, Zhou H, Li BY, et al. Antagonistic effects of berbamine on [Ca2+]i mobilization by KCl, norepinephrine, and caffeine in newborn rat cardiomyocytes. Zhongguo Yao Li Xue Bao. 1999;20:292–296.
- Leung YM, Berdik M, Kwan CY, et al. Effects of tetrandrine and closely related bis-benzylisoquinoline derivatives on cytosolic Ca2+ in human leukaemic HL-60 cells: a structure-activity relationship study. Clin Exp Pharmacol Physiol. 1996;23:653–659.
- Li BY, Zhang YC, Li WH. Effects of berbamine on contraction and Ca2+ influx of pig basilar artery. Zhongguo Yao Li Xue Bao. 1992;13:412–416.
- Powelka AM, Sun J, Li J, et al. Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic. 2004;5:20–36.
- Chairoungdua A, Smith DL, Pochard P, et al. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol. 2010;190:1079–1091.
- Kosaka N, Iguchi H, Yoshioka Y, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010;285:17442–17452.
- Ortega FG, Roefs MT, de Miguel Perez D, et al. Interfering with endolysosomal trafficking enhances release of bioactive exosomes. Nanomedicine. 2019;20:102014.
- Jackson T, Sharma A, Ghazaleh RA, et al. Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha (v) beta3 in vitro. J Virol. 1997;71:8357–8361.
- Gianni T, Gatta V, Campadelli-Fiume G. αVβ3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2. Proc Natl Acad Sci USA. 2010;107:22260–22265.
- Chu JJ-h, Ng M-L. Interaction of West Nile virus with αvβ3 integrin mediates virus entry into cells. J Biol Chem. 2004;279:54533–54541.
- Chu J, Ng M. Characterization of a 105-kDa plasma membrane associated glycoprotein that is involved in West Nile virus binding and infection. Virology. 2003;312:458–469.
- Berinstein A, Roivainen M, Hovi T, et al. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease 7virus to cultured cells. J Virol. 1995;69:2664–2666.
- Westhaus S, Deest M, Nguyen AT, et al. Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load. J Hepatol. 2017;67:237–245.
- Li Y, Kakinami C, Li Q, et al. Human apolipoprotein AI is associated with dengue virus and enhances virus infection through SR-BI. PloS one. 2013;8.
- Raynor CM, Wright JF, Waisman DM, et al. Annexin II enhances cytomegalovirus binding and fusion to phospholipid membranes. Biochemistry. 1999;38:5089–5095.
- Mei M, Ye J, Qin A, et al. Identification of novel viral receptors with cell line expressing viral receptor-binding protein. Sci Rep. 2015;5:7935.
- Gonzalez-Reyes S, García-Manso A, del Barrio G, et al. Role of annexin A2 in cellular entry of rabbit vesivirus. J Gen Virol. 2009;90:2724–2730.
- Wang W, Zhang X, Gao Q, et al. TRPML1: an ion channel in the lysosome. Handb Exp Pharmacol. 2014;222:631–645.
- Venkatachalam K, Wong CO, Zhu MX. The role of TRPMLs in endolysosomal trafficking and function. Cell Calcium. 2015;58:48–56.
- Cheng X, Shen D, Samie M, et al. Mucolipins: intracellular TRPML1-3 channels. FEBS Lett. 2010;584:2013–2021.
- Feng X, Xiong J, Lu Y, et al. Differential mechanisms of action of the mucolipin synthetic agonist, ML-SA1, on insect TRPML and mammalian TRPML1. Cell Calcium. 2014;56:446–456.
- Sakurai Y, Kolokoltsov AA, Chen C-C, et al. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science. 2015;347:995–998.
- Gunaratne GS, Yang Y, Li F, et al. NAADP-dependent Ca(2+) signaling regulates Middle East respiratory syndrome-coronavirus pseudovirus translocation through the endolysosomal system. Cell Calcium. 2018;75:30–41.
- Grimm C, Chen CC, Wahl-Schott C, et al. Two-Pore channels: catalyzers of endolysosomal transport and function. Front Pharmacol. 2017;8:45.
- Patel S. Function and dysfunction of two-pore channels. Sci Signal. 2015;8:re7.
- Go GW, Mani A. Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J Biol Med. 2012;85:19–28.
- Zhou Y, Frey TK, Yang JJ. Viral calciomics: interplays between Ca2+ and virus. Cell Calcium. 2009;46:1–17.
- Scherbik SV, Brinton MA. Virus-induced Ca2+ influx extends survival of west Nile virus-infected cells. J Virol. 2010;84:8721–8731.
- Haughey NJ, Mattson MP. Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J Acquir Immune Defic Syndr. 2002;31:S55–S61.
- Fujioka Y, Nishide S, Ose T, et al. A sialylated voltage-dependent Ca2+ channel binds hemagglutinin and mediates influenza A virus entry into mammalian cells. Cell Host Microbe. 2018;23:809–818. e805.
- Bissig C, Lenoir M, Velluz M-C, et al. Viral infection controlled by a calcium-dependent lipid-binding module in ALIX. Dev Cell. 2013;25:364–373.
- Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol. 2009;10:623–635.
- Luzio JP, Rous BA, Bright NA, et al. Lysosome-endosome fusion and lysosome biogenesis. J Cell Sci. 2000;113:1515–1524.
- Blott EJ, Griffiths GM. Secretory lysosomes. Nat Rev Mol Cell Biol. 2002;3:122–131.
- Shen D, Wang X, Li X, et al. Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat Commun. 2012;3:1–11.
- Pryor PR, Mullock BM, Bright NA, et al. The role of intraorganellar Ca2+ in late endosome–lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J Cell Biol. 2000;149:1053–1062.
- Morgan AJ, Platt FM, Lloyd-Evans E, et al. Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease. Biochem J. 2011;439:349–378.
- Luzio J, Bright N, Pryor P. The role of calcium and other ions in sorting and delivery in the late endocytic pathway. Portland Press Ltd. 2007;35:1088–1091.
- Christensen KA, Myers JT, Swanson JA. pH-dependent regulation of lysosomal calcium in macrophages. J Cell Sci. 2002;115:599–607.
- Zeevi DA, Frumkin A, Bach G. TRPML and lysosomal function. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2007;1772:851–858.
- Bach G. Mucolipin 1: endocytosis and cation channel—a review. Pflügers Archiv. 2005;451:313–317.
- Sun M, Goldin E, Stahl S, et al. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet. 2000;9:2471–2478.
- Berman E, Livni N, Shapira E, et al. Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis. J Pediatr. 1974;84:519–526.
- Bargal R, Avidan N, Ben-Asher E, et al. Identification of the gene causing mucolipidosis type IV. Nat Genet. 2000;26:118–122.
- Zheng Y, Gu S, Li X, et al. Berbamine postconditioning protects the heart from ischemia/reperfusion injury through modulation of autophagy. Cell Death Dis. 2017;8:e2577–e2577.
- Li C, Zhu X, Ji X, et al. Chloroquine, a FDA-approved drug, prevents Zika virus infection and its associated congenital microcephaly in mice. EBioMedicine. 2017;24:189–194.
- Cao B, Parnell LA, Diamond MS, et al. Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice. J Exp Med. 2017;214:2303–2313.
- Baloch AS, Liu C, Liang X, et al. Avian flavivirus enters BHK-21 cells by a Low pH-dependent endosomal pathway. Viruses. 2019;11:1112.
- Huang L, Fu Q, Dai J-M, et al. High-content screening of diterpenoids from isodon species as autophagy modulators and the functional study of their antiviral activities. Cell Biol Toxicol. 2021: 1–19. https://doi.org/https://doi.org/10.1007/s10565-021-09580-6
- Xu Q, Huang L, Xing J, et al. Japanese encephalitis virus manipulates lysosomes membrane for RNA replication and utilizes autophagy components for intracellular growth. Vet Microbiol. 2021;255:109025.
- Gu Y, Zhang J, Ma X, et al. Stabilization of the c-Myc protein by CAMKIIγ promotes T cell lymphoma. Cancer Cell. 2017;32:115–128. e117.
- Gu Y, Chen T, Meng Z, et al. CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine. blood. The Journal of the American Society of Hematology. 2012;120:4829–4839.
- Chang-Xiao Liu PGX, Guo-Sheng L. Studies on plant resources, pharmacology and clinical treatment with berbamine. Phytother Res. 1991;5:228–230.
- MORI M, KAWASAKI S, SACHO M, et al. Effect of cepharanthin on the hemopoietic suppression by X-ray irradiation -- hematological studies (in Japanese). Gann to Kagakuryouhou. 1989;49:667–674.
- Oyaizu H, Adachi Y, Yasumizu R, et al. Protection of T cells from radiation-induced apoptosis by cepharanthin. Int Immunopharmacol. 2001;1:2091–2099.
- Zhang W, Chen SG, Ju HS, et al. Mechanisms of protective effects of berbamine on ischemia/reperfusion injury in isolated rat heart. Methods Find Exp Clin Pharmacol. 1992;14:677–684.